M

Makati Medical Center | Clinical Research Center

Research site

(Unclaimed)

Location

2 Amorsolo Street, Legaspi Village, Makati City, National Capital Region, Philippines

Site insights

Top conditions

Top treatments

Bevacizumab

Tocilizumab

Ritonavir

Avibactam

Thymidine

Fesoterodine

Olanzapine

MTZ

Paclitaxel

Atezolizumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 30 total trials

A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab (IMbrave251)

This is a Phase III, open-label, multicenter, randomized, two-arm study designed to evaluate the efficacy and safety of atezolizumab plus either lenv...

Active, not recruiting

Unresectable Hepatocellular Carcinoma

Drug: Lenvatinib

Drug: Atezolizumab

Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Phase III (COVID-19)

A Global, Multi-center, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Study to Evaluate the Efficacy, Safety, and Immunogenicity o...

Active, not recruiting

COVID-19 Pandemic

Biological: Recombinant SARS-CoV-2 fusion protein vaccine (V-01)

Other: Blank Preparation of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)